Core Viewpoint - Figs (FIGS) shows a significant improvement in earnings outlook, making it an attractive investment option as analysts continue to raise earnings estimates for the company [1][2] Earnings Estimate Revisions - The upward trend in earnings estimate revisions reflects growing analyst optimism regarding Figs' earnings prospects, which is expected to positively impact its stock price [2] - The Zacks Rank system indicates that stocks with strong earnings estimate revisions tend to outperform, with Zacks 1 Ranked stocks averaging a +25% annual return since 2008 [3] - The earnings estimate for the current quarter is $0.01 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 50% over the last 30 days due to one upward revision [6] - For the full year, Figs is expected to earn $0.08 per share, reflecting a year-over-year increase of +300.0%, with three estimates moving higher and no negative revisions [7][8] Zacks Rank and Investment Potential - Figs currently holds a Zacks Rank 1 (Strong Buy) due to favorable estimate revisions, indicating strong potential for investment [9] - Stocks with Zacks Rank 1 and 2 significantly outperform the S&P 500, suggesting that Figs may continue to see positive stock performance [9] - The stock has risen 23.9% over the past four weeks, indicating strong investor interest, with further upside potential still available [10]

Core Insights - Figs (FIGS) is currently outperforming the Retail-Wholesale sector, with a year-to-date gain of approximately 38.1% compared to the sector's average gain of 8.1% [4] - The Zacks Rank system indicates a strong buy rating for Figs, with a current rank of 1, reflecting improved analyst sentiment and a positive earnings outlook [3] Company Performance - Figs is one of 195 companies in the Retail-Wholesale group, which is ranked 11 out of 16 groups in the Zacks Sector Rank [2] - The consensus estimate for Figs' full-year earnings has increased by 38.9% over the past three months, indicating a stronger earnings outlook [3] Industry Comparison - Figs belongs to the Retail - Apparel and Shoes industry, which includes 38 stocks and is currently ranked 44 in the Zacks Industry Rank; this industry has seen an average loss of 18% this year [5] - In contrast, Kingfisher PLC (KGFHY), another stock in the Retail-Wholesale sector, has returned 33.7% year-to-date and belongs to the Retail - Miscellaneous industry, which is ranked 77 [4][6]

Côte Brasserie has announced it will mark this year’s Beaujolais Nouveau Day with a nationwide celebration across its UK restaurants.The popular brasserie will be joining one of France’s most anticipated annual traditions in honouring the arrival of the year’s first wine.Every November, at one minute past midnight on the third Thursday of the month, France erupts in celebration as corks are popped on bottles of freshly bottled Beaujolais Nouveau – a bright, fruit-forward red made from Gamay grapes in the ro ...

Group 1 - The article does not provide any specific content related to a company or industry, as it appears to be a technical issue regarding browser settings and ad-blockers [1]

What Happened? Shares of healthcare apparel company Figs (NYSE:FIGS) jumped 13.2% in the afternoon session after the company reported strong third-quarter financial results that significantly beat Wall Street's expectations. The healthcare apparel company's revenue grew 8.2% year-over-year to $151.7 million, exceeding analyst forecasts. This growth was complemented by a significant earnings beat, with adjusted earnings per share of $0.05, more than double the consensus estimate of $0.02. A key driver for ...

Core Insights - Healthcare apparel company Figs reported Q3 CY2025 revenue of $151.7 million, an 8.2% year-on-year increase, exceeding analyst estimates of $142.5 million [1][5] - The company achieved a non-GAAP profit of $0.05 per share, significantly above the consensus estimate of $0.02 [1][5] - Adjusted EBITDA reached $18.85 million, with a margin of 12.4%, surpassing analyst expectations of $12.38 million [5] Management Commentary - Management attributed the strong performance to consistent execution across core products and disciplined promotional strategies, leading to higher average order values and customer engagement [3][4] - CEO Trina Spear highlighted broad-based growth in scrubwear and the U.S. market, along with improvements in product fit and returns processing [3] - The company plans to maintain momentum through increased inventory investments, new product introductions, and targeted international growth, including the launch of FIBERx fabric at the 2026 Winter Olympics [3] Financial Performance - Operating margin improved to 6.4%, up from -6.2% in the same quarter last year [5] - Active customers increased to 2.78 million, representing a year-on-year growth of 108,000 [5] - Market capitalization stands at $1.23 billion [5] Strategic Initiatives - The deliberate reduction in promotional activity led to higher average order values and improved profitability, with more sales occurring at full price [6] - Growth was primarily driven by the core scrubwear category, with new silhouettes and improved fits reducing return rates [6] - Figs expanded its international presence from 33 to nearly 60 markets, with recent launches in Japan and South Korea, and an upcoming debut in China [6] Product Development - Non-scrubwear categories, including underscrubs, compression socks, and footwear, saw renewed momentum due to targeted product launches [6] - Operational efficiency gains were achieved through supply chain optimization and reduced marketing expenses, despite facing higher tariffs on imports [6]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Motorsport Games Inc. (MSGM) has seen a substantial increase of 122%, trading at $4.88 [3] - Globus Medical, Inc. (GMED) is up 27%, currently priced at $78.75 [3] - JFrog Ltd. (FROG) has risen by 26%, trading at $59.60 [3] - FIGS, Inc. (FIGS) is up 19%, with a trading price of $8.97 [3] - Organogenesis Holdings Inc. (ORGO) has increased by 18%, trading at $4.59 [3] - PureCycle Technologies, Inc. (PCT) is up 17%, currently priced at $11.31 [3] - Expedia Group, Inc. (EXPE) has risen by 16%, trading at $255.10 [3] - 10x Genomics, Inc. (TXG) is up 13%, currently priced at $14.72 [3] - Abacus Global Management, Inc. (ABL) has increased by 12%, trading at $5.95 [3] - GigaCloud Technology Inc. (GCT) is up 9%, currently priced at $27.80 [3] Premarket Losers - Davis Commodities Limited (DTCK) has experienced a significant decline of 65%, trading at $2.23 [4] - Eledon Pharmaceuticals, Inc. (ELDN) is down 46%, currently priced at $2.19 [4] - Treace Medical Concepts, Inc. (TMCI) has decreased by 35%, trading at $4.00 [4] - Energys Group Limited (ENGS) is down 30%, currently priced at $2.77 [4] - Intellia Therapeutics, Inc. (NTLA) has seen a decline of 27%, trading at $8.89 [4] - Fox Factory Holding Corp. (FOXF) is down 24%, currently priced at $16.60 [4] - Opendoor Technologies Inc. (OPEN) has decreased by 24%, trading at $4.94 [4] - AirSculpt Technologies, Inc. (AIRS) is down 21%, currently priced at $8.27 [4] - Power Solutions International, Inc. (PSIX) has seen a decline of 20%, trading at $64.25 [4] - ClearPoint Neuro, Inc. (CLPT) is down 17%, currently priced at $15.00 [4]

Group 1 - The article does not provide any specific information or data regarding companies or industries [1]

Core Insights - Figs (FIGS) reported a revenue of $151.66 million for the quarter ended September 2025, marking an 8.2% year-over-year increase and exceeding the Zacks Consensus Estimate of $142.17 million by 6.67% [1] - The company achieved an EPS of $0.05, a significant improvement from -$0.01 a year ago, resulting in a 150% EPS surprise compared to the consensus estimate of $0.02 [1] Financial Performance Metrics - Active customers reached 2,781, surpassing the average estimate of 2,738 based on five analysts [4] - The average order value was $114.00, slightly above the five-analyst average estimate of $112.06 [4] - Net revenues per active customer were reported at $209.00, closely aligning with the average estimate of $209.04 from two analysts [4] Geographic Revenue Breakdown - Revenue from the Rest of the World was $24.32 million, slightly below the estimated $25.14 million, but reflecting an 11.7% increase year-over-year [4] - U.S. revenues totaled $127.34 million, exceeding the average estimate of $117.18 million, with a year-over-year growth of 7.5% [4] Product Revenue Insights - Non-Scrubwear revenues were reported at $24.65 million, marginally above the average estimate of $24.61 million, showing a year-over-year increase of 7.2% [4] - Scrubwear revenues reached $127.02 million, significantly higher than the average estimate of $117.36 million, with an 8.4% year-over-year growth [4] Stock Performance - Figs shares have returned +9.9% over the past month, outperforming the Zacks S&P 500 composite's +1.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Figs reported quarterly earnings of $0.05 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, and compared to a loss of $0.01 per share a year ago, resulting in an earnings surprise of +150.00% [1] - The company achieved revenues of $151.66 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 6.67% and showing an increase from $140.21 million year-over-year [2] - Figs has outperformed the S&P 500 with a 22.5% gain since the beginning of the year, compared to the S&P 500's gain of 15.6% [3] Earnings Outlook - The future performance of Figs' stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [3][4] - The current consensus EPS estimate for the upcoming quarter is breakeven on revenues of $150.13 million, while for the current fiscal year, it is $0.06 on revenues of $569.84 million [7] Industry Context - The Retail - Apparel and Shoes industry, to which Figs belongs, is currently ranked in the top 22% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Figs' stock performance [5][6]